BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8993353)

  • 1. What happens in vivo to bacterial pathogens?
    Smith H
    Ann N Y Acad Sci; 1996 Oct; 797():77-92. PubMed ID: 8993353
    [No Abstract]   [Full Text] [Related]  

  • 2. Host factors that influence the behaviour of bacterial pathogens in vivo.
    Smith H
    Int J Med Microbiol; 2000 Jul; 290(3):207-13. PubMed ID: 10959722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity.
    Smith H; Parsons NJ; Cole JA
    Microb Pathog; 1995 Dec; 19(6):365-77. PubMed ID: 8852278
    [No Abstract]   [Full Text] [Related]  

  • 4. Questions about the behaviour of bacterial pathogens in vivo.
    Smith H
    Philos Trans R Soc Lond B Biol Sci; 2000 May; 355(1397):551-64. PubMed ID: 10874729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of host lactate on gonococci and meningococci: new concepts on the role of metabolites in pathogenicity.
    Smith H; Tang CM; Exley RM
    Infect Immun; 2007 Sep; 75(9):4190-8. PubMed ID: 17562766
    [No Abstract]   [Full Text] [Related]  

  • 6. Sialic acid activation.
    Kean EL
    Glycobiology; 1991 Nov; 1(5):441-7. PubMed ID: 1668304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element.
    Hammerschmidt S; Hilse R; van Putten JP; Gerardy-Schahn R; Unkmeir A; Frosch M
    EMBO J; 1996 Jan; 15(1):192-8. PubMed ID: 8598202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease.
    Mubaiwa TD; Semchenko EA; Hartley-Tassell LE; Day CJ; Jennings MP; Seib KL
    Pathog Dis; 2017 Jul; 75(5):. PubMed ID: 28633281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Leeuwenhoek Lecture, 1991. The influence of the host on microbes that cause disease.
    Smith H
    Proc Biol Sci; 1991 Nov; 246(1316):97-105. PubMed ID: 1685245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Exoenzymatic Labeling of Lipooligosaccharides of Neisseria gonorrhoeae with α2,6-Sialoside Analogues.
    de Jong H; Moure MJ; Hartman JEM; Bosman GP; Ong JY; Bardoel BW; Boons GJ; Wösten MMSM; Wennekes T
    Chembiochem; 2022 Oct; 23(19):e202200340. PubMed ID: 35877976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
    Kim JJ; Zhou D; Mandrell RE; Griffiss JM
    Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.
    Mandrell RE; Lesse AJ; Sugai JV; Shero M; Griffiss JM; Cole JA; Parsons NJ; Smith H; Morse SA; Apicella MA
    J Exp Med; 1990 May; 171(5):1649-64. PubMed ID: 1692081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase variation of lipopolysaccharide directs interconversion of invasive and immuno-resistant phenotypes of Neisseria gonorrhoeae.
    van Putten JP
    EMBO J; 1993 Nov; 12(11):4043-51. PubMed ID: 7693451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do pathogenic neisseriae need several ways to modify the host cell cytoskeleton?
    Pujol C; Eugène E; Morand P; Nassif X
    Microbes Infect; 2000 Jun; 2(7):821-7. PubMed ID: 10955963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The surface structure seen on gonococci after treatment with CMP-NANA is due to sialylation of surface lipopolysaccharide previously described as a 'capsule'.
    Fox AJ; Curry A; Jones DM; Demarco de Hormaeche R; Parsons NJ; Cole JA; Smith H
    Microb Pathog; 1991 Sep; 11(3):199-210. PubMed ID: 1724790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity.
    Reimer A; Seufert F; Weiwad M; Ebert J; Bzdyl NM; Kahler CM; Sarkar-Tyson M; Holzgrabe U; Rudel T; Kozjak-Pavlovic V
    Int J Antimicrob Agents; 2016 Oct; 48(4):401-8. PubMed ID: 27516227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity and the microbe in vivo. The 1989 Fred Griffith Review Lecture.
    Smith H
    J Gen Microbiol; 1990 Mar; 136(3):377-93. PubMed ID: 2202776
    [No Abstract]   [Full Text] [Related]  

  • 18. Common pathways of invasion of mucosal barriers by Neisseria gonorrhoeae and Neisseria meningitidis.
    McGee ZA; Stephens DS
    Surv Synth Pathol Res; 1984; 3(1):1-10. PubMed ID: 6150544
    [No Abstract]   [Full Text] [Related]  

  • 19. Sialylation of lipopolysaccharide by CMP-NANA in viable gonococci is enhanced by low Mr material released from blood cell extracts but not by some UDP sugars.
    Parsons NJ; Constantinidou C; Cole JA; Smith H
    Microb Pathog; 1994 Jun; 16(6):413-21. PubMed ID: 7830528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of glycosidically linked sialic acid from radiolabeled free sialic acid and cytidine monophosphate-sialic acid by intact hamster fibroblasts: a reexamination.
    Fan P; Datta P
    Biochemistry; 1980 Apr; 19(9):1893-900. PubMed ID: 7378379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.